On December 15, 2023, at the First TCM (Traditional Chinese Medicine) Ecological Conference and TCM Industry Expo, the "Top 50 Comprehensive Competitiveness Index of Traditional Chinese Medicine Enterprises in 2023" was announced. Lingrui Pharmaceutical proudly secured the 28th spot, achieving a comprehensive score of 322.91 across three criteria.
From January to November 2023, Lingrui Pharmaceutical generated a tax revenue of 464 million yuan. The company's "Two Tigers" series of plasters have achieved an annual sales volume of over 1 billion patches. Lingrui has been honored with over 20 provincial and national recognitions, including "National Key High-tech Enterprise" and "National Intelligent Manufacturing Digital Factory," and has been designated a "National Technology Innovation Demonstration Enterprise" by the Ministry of Industry and Information Technology.
As a leader in the health industry cluster in Xin County, Henan Province, Lingrui Pharmaceutical has successfully established the Henan Provincial Institute of Modernized Traditional Chinese Medicine Industry, the Innovation Consortium, and the Provincial Key Laboratory of Transdermal Drug Delivery Preparations. In 2023, the Lingrui Biological External Ointment Automated Production Line Upgrading and Renovation Project, a key provincial project, was put into production.